151 related articles for article (PubMed ID: 17895825)
1. Treatment of nonarteritic anterior ischemic optic neuropathy with intravitreal bevacizumab.
Bennett JL; Thomas S; Olson JL; Mandava N
J Neuroophthalmol; 2007 Sep; 27(3):238-40. PubMed ID: 17895825
[No Abstract] [Full Text] [Related]
2. Intravitreal triamcinolone for nonarteritic anterior ischemic optic neuropathy.
Hayreh SS
J Neuroophthalmol; 2008 Mar; 28(1):77-8; author reply 78-9. PubMed ID: 18347467
[No Abstract] [Full Text] [Related]
3. Intravitreal triamcinolone or bevacizumab for nonarteritic anterior ischemic optic neuropathy: do they merit further study?
Kelman SE
J Neuroophthalmol; 2007 Sep; 27(3):161-3. PubMed ID: 17895813
[No Abstract] [Full Text] [Related]
4. Is intravitreal bevacizumab an effective treatment option for nonarteritic anterior ischemic optic neuropathy?
Prescott CR; Sklar CA; Lesser RL; Adelman RA
J Neuroophthalmol; 2012 Mar; 32(1):51-3. PubMed ID: 22269947
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal triamcinolone improves recovery of visual acuity in nonarteritic anterior ischemic optic neuropathy.
Kaderli B; Avci R; Yucel A; Guler K; Gelisken O
J Neuroophthalmol; 2007 Sep; 27(3):164-8. PubMed ID: 17895814
[TBL] [Abstract][Full Text] [Related]
6. Anterior ischemic optic neuropathy following intravitreal bevacizumab.
Huang JY; Ozaki H; Hayashi H; Uchio E
Jpn J Ophthalmol; 2010 May; 54(3):252-4. PubMed ID: 20577866
[No Abstract] [Full Text] [Related]
7. Reflux after intravitreal injection of bevacizumab.
Boon CJ; Crama N; Klevering BJ; van Kuijk FJ; Hoyng CB
Ophthalmology; 2008 Jul; 115(7):1270; author reply 1271. PubMed ID: 18598829
[No Abstract] [Full Text] [Related]
8. Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.
Kook D; Wolf A; Kreutzer T; Neubauer A; Strauss R; Ulbig M; Kampik A; Haritoglou C
Retina; 2008 Oct; 28(8):1053-60. PubMed ID: 18779710
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal ranibizumab injection for nonarteritic ischemic optic neuropathy.
Pece A; Querques G; Quinto A; Isola V
J Ocul Pharmacol Ther; 2010 Oct; 26(5):523-7. PubMed ID: 20874667
[TBL] [Abstract][Full Text] [Related]
10. Insight into 8 patients with nonarteritic anterior ischemic optic neuropathy following anti-VEGF injections.
Mansour AM; Schwartz SG; Gregori NZ; Yehoshua Z; Freund KB; Dellatorre K; Aisenbrey S; Hosseini H; Huang JY; Bodla AA; Bhatti MT
J Neuroophthalmol; 2012 Jun; 32(2):193. PubMed ID: 22549561
[No Abstract] [Full Text] [Related]
11. Intravitreal bevacizumab for diabetic papillopathy.
Ornek K; Oğurel T
J Ocul Pharmacol Ther; 2010 Apr; 26(2):217-8. PubMed ID: 20334555
[TBL] [Abstract][Full Text] [Related]
12. Outcome of bevacizumab (Avastin) injection in patients with age-related macular degeneration and low visual acuity.
Ehrlich R; Weinberger D; Priel E; Axer-Siegel R
Retina; 2008 Oct; 28(9):1302-7. PubMed ID: 18664935
[TBL] [Abstract][Full Text] [Related]
13. Anterior ischemic optic neuropathy after intravitreal injection of bevacizumab.
Hosseini H; Razeghinejad MR
J Neuroophthalmol; 2009 Jun; 29(2):160-1. PubMed ID: 19491650
[No Abstract] [Full Text] [Related]
14. Effects of intravitreal bevacizumab treatment on proliferative retinopathy in a patient with cerebroretinal vasculopathy.
Kernt M; Gschwendtner A; Neubauer AS; Dichgans M; Haritoglou C
J Neurol; 2010 Jul; 257(7):1213-4. PubMed ID: 20179959
[No Abstract] [Full Text] [Related]
15. Central retinal sensitivity after intravitreal injection of bevacizumab for myopic choroidal neovascularization.
Yodoi Y; Tsujikawa A; Nakanishi H; Otani A; Tamura H; Ojima Y; Hayashi H; Yoshimura N
Am J Ophthalmol; 2009 May; 147(5):816-24, 824.e1. PubMed ID: 19211092
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal bevacizumab injection for central serous chorioretinopathy.
Nowroozzadeh MH
Retina; 2010 Sep; 30(8):1322-3; author reply 1323. PubMed ID: 20827148
[No Abstract] [Full Text] [Related]
17. Intravitreal bevacizumab injection for central serous chorioretinopathy.
Chhablani JK; Narayanan R
Retina; 2010 Sep; 30(8):1323-24; author reply 1324. PubMed ID: 20661171
[No Abstract] [Full Text] [Related]
18. Diffuse diabetic macular oedema treated with intravitreal bevacizumab or triamcinolone acetonide.
Rensch F; Spandau UH; Wickenhäuser A; Jonas JB
Acta Ophthalmol; 2010 Mar; 88(2):e36-7. PubMed ID: 19210330
[No Abstract] [Full Text] [Related]
19. Anterior ischemic optic neuropathy.
Entezari M; Ramezani A; Pakravan M; Mahmoodi A; Hassanpour H; Yaseri M
Ophthalmology; 2012 Apr; 119(4):879-80. PubMed ID: 22472252
[No Abstract] [Full Text] [Related]
20. Efficacy and safety of one intravitreal injection of bevacizumab in diabetic macular oedema.
Kumar V; Ghosh B; Raina UK; Goel N
Acta Ophthalmol; 2010 Mar; 88(2):e3; author reply e4. PubMed ID: 19549100
[No Abstract] [Full Text] [Related]
[Next] [New Search]
